OPRK1 and Respiratory insufficiency due to muscle weakness: Prior studies have demonstrated that KOR-specific agonists exhibit antinociceptive effects and, unlike morphine and other opioid analgesics, KOR agonists do not result in respiratory depression or addictive effects (35).